The C-terminal 42 residues of the tula virus Gn protein regulate interferon induction

Journal of Virology

Volumn 85, Issue 10, 2011, Pages 4752-4760

  Matthys, Valery ^a   Gorbunova, Elena E ^a   Gavrilovskaya, Irina N ^a   Pepini, Timothy ^a   Mackow, Erich R ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CARRIER PROTEINS AND BINDING PROTEINS; INTERFERON REGULATORY FACTOR 3; RETINOIC ACID INDUCIBLE PROTEIN I; TBK1 PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN COS7; CELL STRAIN HEK293; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENDOTHELIUM CELL; GENE; HANTAVIRUS; HUMAN; HUMAN CELL; INTERFERON INDUCTION; INTERFERON STIMULATED RESPONSE ELEMENT; ISG56 GENE; MXA GENE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSPECT HILL VIRUS; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; TULA VIRUS; VERO CELL;

ANIMALS; CELL LINE; DOWN-REGULATION; GENE EXPRESSION PROFILING; HANTAVIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERONS; VIRAL PROTEINS;

HANTAVIRUS; PROSPECT HILL VIRUS; TULA VIRUS;

EID: 79955414003     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01945-10     Document Type: Article

References (54)

1. Alff, P. J., et al. 2006. The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J. Virol. 80:9676-9686.
2. Alff, P. J., N. Sen, E. Gorbunova, I. N. Gavrilovskaya, and E. R. Mackow. 2008. The NY-1 hantavirus Gn cytoplasmic tail coprecipitates TRAF3 and inhibits cellular interferon responses by disrupting TBK1-TRAF3 complex formation. J. Virol. 82:9115-9122.
3. Borges, E., Y. Jan, and E. Ruoslahti. 2000. Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain. J. Biol. Chem. 275:39867-39873.
4. Brakenhielm, E. 2007. Substrate matters: reciprocally stimulatory integrin and VEGF signaling in endothelial cells. Circ. Res. 101:536-538.
5. Clement, J. P. 2003. Hantavirus. Antiviral Res. 57:121-127.
6. Estrada, D. F., D. M. Boudreaux, D. Zhong, S. C. St Jeor, and R. N. De Guzman. 2009. The hantavirus glycoprotein G1 tail contains dual CCHC-type classical zinc fingers. J. Biol. Chem. 284:8654-8660.
7. Gavrilovskaya, I. N., E. J. Brown, M. H. Ginsberg, and E. R. Mackow. 1999. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by β3 integrins. J. Virol. 73:3951-3959.
8. Gavrilovskaya, I. N., E. E. Gorbunova, and E. R. Mackow. 2010. Pathogenic hantaviruses direct the adherence of quiescent platelets to infected endothelial cells. J. Virol. 84:4832-4839.
9. Gavrilovskaya, I. N., E. E. Gorbunova, N. A. Mackow, and E. R. Mackow. 2008. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphin-gosine 1-phosphate inhibit hantavirus-directed permeability. J. Virol. 82: 5797-5806.
10. Gavrilovskaya, I. N., T. Peresleni, E. Geimonen, and E. R. Mackow. 2002. Pathogenic hantaviruses selectively inhibit β3 integrin directed endothelial cell migration. Arch. Virol. 147:1913-1931.
11. Gavrilovskaya, I. N., M. Shepley, R. Shaw, M. H. Ginsberg, and E. R. Mackow. 1998. β3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc. Natl. Acad. Sci. U. S. A. 95:7074-7079.
12. Geimonen, E., I. Fernandez, I. N. Gavrilovskaya, and E. R. Mackow. 2003. Tyrosine residues direct the ubiquitination and degradation of the NY-1 hantavirus G1 cytoplasmic tail. J. Virol. 77:10760-10868.
13. Geimonen, E., et al. 2003. Hantavirus pulmonary syndrome-associated hantaviruses contain conserved and functional ITAM signaling elements. J. Virol. 77:1638-1643.
14. Geimonen, E., et al. 2002. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc. Natl. Acad. Sci. U. S. A. 99:13837-13842.
15. Gonzalez-Navajas, et al. 2010. Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven anti-inflammatory cytokine production. J. Exp. Med. 207:2799-2807.
16. Gorbunova, E., I. N. Gavrilovskaya, and E. R. Mackow. 2010. Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cells. J. Virol. 84:7405-7411.
17. Hacker, H., et al. 2006. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439:204-207.
18. Hepojoki, J., et al. 2010. Cytoplasmic tails of hantavirus glycoproteins interact with the nucleocapsid protein. J. Gen. Virol. 91:2341-2350.
19. Hiscott, J. 2007. Convergence of the NF-κB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 18: 483-490.
20. Hiscott, J. 2007. Triggering the innate antiviral response through IRF-3 activation. J. Biol. Chem. 282:15325-15329.
21. Hiscott, J., et al. 2003. Convergence of the NF-KB and interferon signaling pathways in the regulation of antiviral defense and apoptosis. Ann. N. Y. Acad. Sci. 1010:237-248.
22. Jaaskelainen, K. M., et al. 2007. Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter. J. Med. Virol. 79:1527-1536.
23. Jaaskelainen, K. M., A. Plyusnina, A. Lundkvist, A. Vaheri, and A. Plyusnin. 2008. Tula hantavirus isolate with the full-length ORF for nonstructural protein NSs survives for more consequent passages in interferon-competent cells than the isolate having truncated NSs ORF. Virol. J. 5:3.
24. Johnson, K. M. 2001. Hantaviruses: history and overview. Curr. Top. Microbiol. Immunol. 256:1-14.
25. Kanerva, M., K. Melen, A. Vaheri, and I. Julkunen. 1996. Inhibition of Puumala and Tula hantaviruses in Vero cells by MxA protein. Virology 224:55-62.
26. Kawai, T., and S. Akira. 2005. Pathogen recognition with Toll-like receptors. Curr. Opin. Immunol. 17:338-344.
27. Kawai, T., et al. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-988.
28. Kraus, A. A., et al. 2004. Differential antiviral response of endothelial cells after infection with pathogenic and nonpathogenic hantaviruses. J. Virol. 78:6143-6150.
29. Levine, J. R., et al. 2010. Antagonism of type I interferon responses by new world hantaviruses. J. Virol. 84:11790-11801.
30. Li, X. D., et al. 2004. Tula hantavirus infection of Vero E6 cells induces apoptosis involving caspase 8 activation. J. Gen. Virol. 85:3261-3268.
31. Liang, J., et al. 2010. MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-κB signaling. J. Exp. Med. 207: 2959-2973.
32. Mackow, E. R., and I. N. Gavrilovskaya. 2009. Hantavirus regulation of endothelial cell functions. Thromb. Haemost. 102:1030-1041.
33. 3 integrins is determined by an L33P substitution in the PSI domain. J. Virol. 84:352-360.
34. Oganesyan, G., et al. 2006. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439:208-211.
35. Ontiveros, S. J., Q. Li, and C. B. Jonsson. 2010. Modulation of apoptosis and immune signaling pathways by the Hantaan virus nucleocapsid protein. Virology 401:165-178.
36. Pensiero, M. N., J. B. Sharefkin, C. W. Dieffenbach, and J. Hay. 1992. Hantaan virus infection of human endothelial cells. J. Virol. 66:5929-5936.
37. Plyusnin, A., et al. 1994. Tula virus: a newly detected hantavirus carried by European common voles. J. Virol. 68:7833-7839.
38. Rani, M. R., and R. M. Ransohoff. 2005. Alternative and accessory pathways in the regulation of IFN-beta-mediated gene expression. J. Interferon Cytokine Res. 25:788-798.
39. 3 integrin conformers. Proc. Natl. Acad. Sci. U. S. A. 102:1163-1168.
40. Schmaljohn, C, and B. Hjelle. 1997. Hantaviruses: a global disease problem. Emerg. Infect. Dis. 3:95-104.
41. Sen, N., A. Sen, and E. R. Mackow. 2007. Degrons at the C terminus of the pathogenic but not the nonpathogenic hantavirus G1 tail direct proteasomal degradation. J. Virol. 81:4323-4330.
42. Seth, R. B., L. Sun, and Z. J. Chen. 2006. Antiviral innate immunity pathways. Cell Res. 16:141-147.
43. Spiropoulou, C. F., C. G. Albarino, T. G. Ksiazek, and P. E. Rollin. 2007. Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J. Virol. 81:2769-2776.
44. Taylor, S. L., N. Frias-Staheli, A. Garcia-Sastre, and C. S. Schmaljohn. 2009. Hantaan virus nucleocapsid protein binds to importin alpha proteins and inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappa B. J. Virol. 83:1271-1279.
45. Taylor, S. L., R. L. Krempel, and C. S. Schmaljohn. 2009. Inhibition of TNF-alpha-induced activation of NF-κB by hantavirus nucleocapsid proteins. Ann. N. Y. Acad. Sci. 1171(Suppl. 1):E86-E93.
46. Vapalahti, O., et al. 1996. Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae. J. Gen. Virol. 77:3063-3067.
47. Virtanen, J. O., K. M. Jaaskelainen, J. Djupsjobacka, A. Vaheri, and A. Plyusnin. 2010. Tula hantavirus NSs protein accumulates in the perinuclear area in infected and transfected cells. Arch. Virol. 155:117-121.
48. Wang, H., A. Alminaite, A. Vaheri, and A. Plyusnin. 2010. Interaction between hantaviral nucleocapsid protein and the cytoplasmic tail of surface glycoprotein Gn. Virus Res. 151:205-212.
49. Wang, H., T. Strandin, J. Hepojoki, H. Lankinen, and A. Vaheri. 2009. Degradation and aggresome formation of the Gn tail of the apathogenic Tula hantavirus. J. Gen. Virol. 90:2995-3001.
50. Yanagihara, R., and D. J. Silverman. 1990. Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses. Arch. Virol. 111:281-286.
51. Yoneyama, M., and T. Fujita. 2007. Function of RIG-I-like receptors in antiviral innate immunity. J. Biol. Chem. 282:15315-15318.
52. Yoneyama, M., et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-737.
53. Zaki, S., et al. 1995. Hantavirus Pulmonary Syndrome: pathogenesis of an emerging infectious disease. Am. J. Pathol. 146:552-579.
54. Zhu, S., et al. 2010. Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling. J. Exp. Med. 207:2647-2662.